InvestorsHub Logo
Followers 135
Posts 13927
Boards Moderated 0
Alias Born 09/05/2013

Re: Garden Rose post# 243

Tuesday, 04/07/2020 8:14:58 AM

Tuesday, April 07, 2020 8:14:58 AM

Post# of 23080
Without actual cases or numbers of chloroquine treatments, it would be conjecture to blame the medicine before the disease, not to mention putting the cart before the horse.

The link I quoted says the doctors believe the patient's hearts are being "infected", not "affected". There is organ damage occurring even in infected people who don't show any outward symptoms from the infection. I don't think patients without symptoms are being prescribed chloroquine.

Going forward, the Gates Foundation has just put millions into "researching" chloroquine, and other factions are doing the same. My prediction is that by the end of this month, we will see lots of diametrically opposed information about that drug. There are lots of rich and powerful people who have invested their lives and their wealth into an economy that will be based on vaccines and tracking chips, like we are stray dogs. It would be an understatement to say that they "need" the solution to be a vaccine.

Teaching an old drug new tricks
One of the benefits of researching existing approved drugs is that we already know they’re safe – so we can move quickly to repurpose them for other uses. New drugs have to go through years of safety trials before they become available.
Hydroxychloroquine and chloroquine have been safely used in millions of people, including children. While there have been reports of dangerous side effects, with people self-medicating as an option to treat COVID-19, the drugs were often taken in inappropriate doses or formulations. No one should try to take drugs until we know how they can be used safely for a disease.


https://wellcome.ac.uk/news/can-chloroquine-prevent-coronavirus-disease-only-research-will-give-us-answer
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.